Candida clinical species identification: molecular and biochemical methods

被引:9
作者
Costa, Ana Rita [1 ]
Silva, Filipe [2 ]
Henriques, Mariana [1 ]
Azeredo, Joana [1 ]
Oliveira, Rosario [1 ]
Faustino, Alberta [1 ]
机构
[1] Univ Minho, Ctr Biol Engn, Inst Biotechnol & Bioengn, P-4710057 Braga, Portugal
[2] Hosp S Marcos, P-4701965 Braga, Portugal
关键词
Candida species; Discriminating potential; PCR; Vitek; 2; YST; Auxacolor; ID32C; NOSOCOMIAL FUNGAL-INFECTIONS; EMERGING YEAST PATHOGENS; PCR-BASED IDENTIFICATION; AUXACOLOR SYSTEM; RISK-FACTORS; ALBICANS; DUBLINIENSIS; EPIDEMIOLOGY; DNA; PRIMERS;
D O I
10.1007/s13213-009-0007-6
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In the last decade, the number and diversity of nosocomial Candida infections has increased significantly, resulting in an emergent need for rapid and accurate methods for Candida identification. Therefore, the aim of this study was to evaluate the performance of three biochemical systems (Auxacolor, ID32C, and Vitek 2 YST) for the identification of Candida species, comparing them with molecular identification (polymerase chain reaction and gel agarose electrophoresis). These methods were used to assess Candida spp. (229 clinical isolates) prevalence and distribution among clinical specimens. The biochemical methods with higher percentages of correct identification were Vitek 2 YST (79.6%) and Auxacolor (78.6%). However, overall the biochemical methods assayed differed from the molecular identification. Thus, due to their rapid and precise identification, molecular methods are promising techniques for Candida species identification in clinical laboratories. Candida albicans and Non Candida albicans Candida species had a similar prevalence (50.4 and 49.6%, respectively), corroborating the epidemiological shift observed for these pathogens in the recent years.
引用
收藏
页码:105 / 112
页数:8
相关论文
共 34 条
[1]   Specific identification of Candida albicans and Candida dubliniensis by PCR using species-specific primers [J].
Abaci, Oezlem ;
Halki-Uztan, Alev ;
Ates, Mustafa .
ANNALS OF MICROBIOLOGY, 2008, 58 (02) :325-331
[2]  
BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247
[3]   Comparison of the API Candida system with the AUXACOLOR system for identification of common yeast pathogens [J].
Campbell, CK ;
Davey, KG ;
Holmes, AD ;
Szekely, A ;
Warnock, DW .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (03) :821-823
[4]  
Crocco Elisete I., 2004, An. Bras. Dermatol., V79, P689, DOI 10.1590/S0365-05962004000600005
[5]   Comparison of RapID yeast plus system with API 20C system for identification of common, new, and emerging yeast pathogens [J].
Espinel-Ingroff, A ;
Stockman, L ;
Roberts, G ;
Pincus, D ;
Pollack, J ;
Marler, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (04) :883-886
[6]   COMPARISON OF UPDATED VITEK YEAST BIOCHEMICAL CARD AND API 20C YEAST IDENTIFICATION SYSTEMS [J].
FENN, JP ;
SEGAL, H ;
BARLAND, B ;
DENTON, D ;
WHISENANT, J ;
CHUN, H ;
CHRISTOFFERSON, K ;
HAMILTON, L ;
CARROLL, K .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (05) :1184-1187
[7]   In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest [J].
Fleck, Ralf ;
Dietz, Annebaerbel ;
Hof, Herbert .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (04) :767-771
[8]  
FRICKERHIDALGO H, 1995, ANN BIOL CLIN-PARIS, V53, P221
[9]   Epidemiology of nosocomial fungal infections [J].
Fridkin, SK ;
Jarvis, WR .
CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (04) :499-&
[10]   CLINICAL-FEATURES AND ANALYSIS OF RISK-FACTORS FOR INVASIVE CANDIDAL INFECTION AFTER MARROW TRANSPLANTATION [J].
GOODRICH, JM ;
REED, EC ;
MORI, M ;
FISHER, LD ;
SKERRETT, S ;
DANDLIKER, PS ;
KLIS, B ;
COUNTS, GW ;
MEYERS, JD .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (04) :731-740